Stem cell transplant using half-matched or unrelated donors
Part of Cancer clinical trials.
This trial tests a special type of stem cell transplant for people who don't have a perfectly matched sibling donor. It uses stem cells from a half-matched family member or a closely matched unrelated donor to treat cancers or other serious disorders.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a disease (like cancer or a blood disorder) that a stem cell transplant might help treat.
- You do not have a healthy sibling who is a perfect tissue (HLA) match.
- You have either a half-matched family donor (like a parent or child) OR a closely matched unrelated donor from a registry.
- The donor must be healthy enough to receive a medicine that boosts stem cells and have those cells collected from their blood.
- You must be healthy enough for a transplant (good organ function, no serious infections, and not pregnant if you could become pregnant).
- You cannot have an allergy to mouse proteins or iron dextran.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 trial tests whether a specific stem cell transplant method (from a related “half-matched” donor) plus conditioning chemo and radiation can improve outcomes for several blood cancers. It may help people whose cancer is in remission but still considered high risk, or those who have had limited response after prior treatment.
This Phase 2 study tests a specific chemotherapy combination (treosulfan, fludarabine, and thiotepa) before an unrelated or matched donor stem cell transplant. It may help people with certain non-cancer blood and immune disorders by trying to reset the immune system using donor stem cells.
This trial tests a transplant using stem cells from an unrelated donor who is not a perfect match for your tissue type. It may be an option for people with blood cancers who can't find a fully matched related donor and need a transplant quickly.
This trial tests a stem cell transplant from a family donor whose tissue type is only partly matched, for adults with blood cancers who don't have a fully matched sibling or other closely matched donor. The goal is to make transplant possible for more patients.
This trial tests a new way to do a stem cell transplant for people with hard-to-treat blood cancers. It combines a half-matched family donor (haploidentical) with a cord blood unit to help the transplant work better.
This study tests a special stem cell transplant for children and young adults with certain high-risk blood cancers or bone marrow diseases. It uses a half-matched family donor and a technique to remove specific cells, which may lower the risk of side effects and help the body accept the new cells.
Hear when a new Benign Neoplasm trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.